학술논문

Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study
Document Type
Article
Source
In Clinical Therapeutics January 2017 39(1):118-129
Subject
Language
ISSN
0149-2918